PBPIA
Pivotal bioVenture Partners Investment Advisor’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.7M | Hold |
2,120,508
| – | – | 18.43% | 3 |
|
|
2025
Q1 | $33.2M | Hold |
2,120,508
| – | – | 26.84% | 2 |
|
|
2024
Q4 | $29.5M | Hold |
2,120,508
| – | – | 19.95% | 3 |
|
|
2024
Q3 | $19.7M | Buy |
2,120,508
+79,400
| +4% | +$738K | 11.71% | 3 |
|
|
2024
Q2 | $19M | Buy |
2,041,108
+13,100
| +0.6% | +$122K | 14.59% | 4 |
|
|
2024
Q1 | $20.1M | Buy |
2,028,008
+117,999
| +6% | +$1.17M | 12.92% | 3 |
|
|
2023
Q4 | $6.17M | Buy |
1,910,009
+804,700
| +73% | +$2.6M | 1.57% | 7 |
|
|
2023
Q3 | $5.87M | Hold |
1,105,309
| – | – | 2.34% | 6 |
|
|
2023
Q2 | $10.5M | Buy |
1,105,309
+536,268
| +94% | +$5.11M | 3.47% | 6 |
|
|
2023
Q1 | $6.26M | Hold |
569,041
| – | – | 2.58% | 6 |
|
|
2022
Q4 | $8.42M | Hold |
569,041
| – | – | 3.66% | 4 |
|
|
2022
Q3 | $10.9M | Hold |
569,041
| – | – | 3.97% | 5 |
|
|
2022
Q2 | $12.1M | Hold |
569,041
| – | – | 6.11% | 5 |
|
|
2022
Q1 | $11M | Hold |
569,041
| – | – | 5.19% | 6 |
|
|
2021
Q4 | $11.8M | Hold |
569,041
| – | – | 4.93% | 6 |
|
|
2021
Q3 | $13.6M | Hold |
569,041
| – | – | 4.8% | 8 |
|
|
2021
Q2 | $15.5M | Hold |
569,041
| – | – | 6.12% | 7 |
|
|
2021
Q1 | $16.5M | Sell |
569,041
-102,675
| -15% | -$2.97M | 5.28% | 8 |
|
|
2020
Q4 | $18.9M | Buy |
+671,716
| New | +$18.9M | 6.23% | 6 |
|